D - Trademark Details
Status: 700 - Registered
Serial Number
79278708
Registration Number
6235899
Word Mark
D
Status
700 - Registered
Status Date
2021-01-05
Filing Date
2019-08-28
Registration Number
6235899
Registration Date
2021-01-05
Mark Drawing
5000 - Illustration: Drawing with word(s)/letter(s)/number(s) in Stylized form
Typeset
Design Searches
160305 - Binoculars, opera glasses, telescopes, microscopes.
Published for Opposition Date
2020-10-20
Attorney Name
Law Office Assigned Location Code
O10
Employee Name
HOFFMAN, CHRISTOPHER J
Statements
Indication of Colors claimed
Color is not claimed as a feature of the mark.
Description of Mark
The mark consists of the stylized letter "D".
Goods and Services
Antiseptics; vaccines; veterinary preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vitamin preparations; disinfectants; diagnostic preparations for veterinary purposes; diagnostic preparations for medical purposes; dietetic beverages adapted for medical purposes; Dietetic foods and beverages adapted for medical use; dietetic foods adapted for medical purposes; plant extracts for pharmaceutical purposes; herbal extracts for medical purposes; Capsules sold empty for pharmaceuticals; medicinal preparations for human purposes for medicines for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Drugs being pharmaceutical preparations for medical purposes for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Medicinal drinks; medicinal oils; medicated toiletry preparations; medicated shampoos; ointments for pharmaceutical purposes, namely, medicated ointments for treating dermatological conditions and antibiotic ointments; teeth filling material; medicinal alcohol; food supplements; medical dressings; nutritional supplements; Pre-filled syringes containing pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Air purifying preparations; food for babies; protein dietary supplements; Tissues impregnated with pharmaceutical lotions for treating dermatological conditions; Alcohol for pharmaceutical purposes; stem cells for medical purposes; transplants, namely, surgical implants comprising living tissue used in transplant operations; pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; ferments for pharmaceutical purposes; phytotherapy preparations for medical purposes; chemico-pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Chemical preparations for medical purposes for the diagnosis of pregnancy; Chemical preparations for pharmaceutical purposes for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; surgical dressings; candy, medicated; candy for medical purposes; sanitary preparations for medical purposes, namely, medicated toiletry preparations; plasters for medical purposes
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2020-02-19
Primary Code
005
Current Trademark Owners
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
01 - Individual
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
01 - Individual
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
20 - Owner at Publication
Legal Entity Type
01 - Individual
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
10 - Original Applicant
Legal Entity Type
01 - Individual
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Iryna Vyshynska
Address
Please log in with your Justia account to see this address.
International Registrations
International Registration Number
1514494
International Registration Date
2019-08-28
International Publication Date
2020-02-13
International Renewal Date
2029-08-28
Auto Protection Date
2021-08-13
International Status
001 - Request for extension of protection established
International Status Date
2020-02-13
Priority Claimed In
False
First Refusal In
True
Trademark Events
| Event Date | Event Description |
| 2020-02-13 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| 2020-02-19 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| 2020-02-19 | ASSIGNED TO EXAMINER |
| 2020-02-19 | NON-FINAL ACTION WRITTEN |
| 2020-02-20 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| 2020-02-25 | APPLICATION FILING RECEIPT MAILED |
| 2020-03-11 | REFUSAL PROCESSED BY MPU |
| 2020-03-11 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| 2020-03-28 | REFUSAL PROCESSED BY IB |
| 2020-08-12 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 2020-08-12 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 2020-08-12 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 2020-08-13 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 2020-08-31 | ASSIGNED TO LIE |
| 2020-09-01 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 2020-09-01 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 2020-09-14 | EXAMINERS AMENDMENT -WRITTEN |
| 2020-09-14 | EXAMINERS AMENDMENT E-MAILED |
| 2020-09-14 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| 2020-09-14 | EXAMINER'S AMENDMENT ENTERED |
| 2020-09-15 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 2020-09-30 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 2020-09-30 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| 2020-09-30 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| 2020-10-18 | NOTIFICATION PROCESSED BY IB |
| 2020-10-20 | PUBLISHED FOR OPPOSITION |
| 2020-10-20 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 2020-12-18 | NEW REPRESENTATIVE AT IB RECEIVED |
| 2021-01-05 | REGISTERED-PRINCIPAL REGISTER |
| 2021-04-05 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| 2021-04-10 | FINAL DISPOSITION PROCESSED |
| 2021-04-11 | FINAL DISPOSITION NOTICE SENT TO IB |
| 2021-05-02 | FINAL DECISION TRANSACTION PROCESSED BY IB |
